American Society of Clinical Oncology

SHERPA: White

People

  1. Antonescu
    Antonescu
  2. Keohan
    Keohan
  3. Maki
    Maki
  4. Dickson
    Dickson
  5. Hensley
    Hensley
  6. Kelsen
    Kelsen
  7. Qin
    Qin
  8. Schwartz
    Schwartz
  9. Teitcher
    Teitcher

Groups

  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Sarcoma Service (3)
  4. Advanced Practice Providers (2)
  5. Body Imaging Service (2)
  6. GSK Faculty (2)
  7. Nursing (2)
  8. Radiology, Department of (2)
  9. Tow Center for Developmental Oncology (TCDO) (2)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
Search Within
  1. "2009"
  2. "Gary Schwartz"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Sarcoma Service (3)
  4. Advanced Practice Providers (2)
  5. Body Imaging Service (2)
  6. GSK Faculty (2)

More Groups

People
  1. Gary Schwartz (6)
  2. Cristina Antonescu (2)
  3. David D'Adamo (2)
  4. Heather Dials (2)
  5. Lauren Cane (2)
  6. Mary Keohan (2)

More People

Years
  1. 2009 (6)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Robertson, S.; Shen, A.; Wang, E.; Pace, L.; Dials, H.; Mendelson, D.; Shannon, P.; Gordon, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
    Journal Article

    Maki, R. G.; D'adamo, D. R.; Keohan, M. L.; Saulle, M.; Schuetze, S. M.; Undevia, S. D.; Livingston, M. B.; Cooney, M. M.; Hensley, M. L.; Mita, M. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas
    Journal Article

    George, S.; Merriam, P.; Maki, R. G.; Van Den Abbeele, A. D.; Yap, J. T.; Akhurst, T.; Harmon, D. C.; Bhuchar, G.; O'Mara, M. M.; D'adamo, D. R.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114)
    Journal Article

    Schwartz, G. K.; Winter, K.; Minsky, B. D.; Crane, C.; Thomson, P. J.; Anne, P.; Gross, H.; Willett, C.; Kelsen, D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save